Tafamidis

Tafamidis is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs.

Tafamidis Chemical Structure

Tafamidis Chemical Structure

CAS No. 594839-88-0

Purity & Quality Control

Tafamidis Related Products

Biological Activity

Description Tafamidis is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06086353 Recruiting
Transthyretin Amyloid Cardiomyopathy
Pfizer
March 25 2024 --
NCT05938218 Not yet recruiting
Amyloidosis Cardiac|Virtual Reality
Heinrich-Heine University Duesseldorf
December 1 2023 Not Applicable
NCT05489523 Recruiting
Transthyretin Cardiac Amyloidosis
University of Texas Southwestern Medical Center
May 1 2023 Phase 4
NCT05560555 Completed
Hereditary Transthyretin Amyloidosis (ATTRv)|Polyneuropathy
Pfizer
October 24 2022 --
NCT05374564 Recruiting
Cardiomyopathies Primary
Yale University|Pfizer
August 16 2022 Phase 1
NCT04814186 Completed
Transthyretin Amyloid Cardiomyopathy
Pfizer
July 22 2021 Phase 4

Chemical Information & Solubility

Molecular Weight 308.12 Formula

C14H7Cl2NO3

CAS No. 594839-88-0 SDF --
Smiles C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 31 mg/mL ( (100.61 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tafamidis | Tafamidis ic50 | Tafamidis price | Tafamidis cost | Tafamidis solubility dmso | Tafamidis purchase | Tafamidis manufacturer | Tafamidis research buy | Tafamidis order | Tafamidis mouse | Tafamidis chemical structure | Tafamidis mw | Tafamidis molecular weight | Tafamidis datasheet | Tafamidis supplier | Tafamidis in vitro | Tafamidis cell line | Tafamidis concentration | Tafamidis nmr